T. Rowe Price Health Care ETF (TMED)
| Assets | $24.83M |
| Expense Ratio | 0.44% |
| PE Ratio | 29.13 |
| Shares Out | 775,000 |
| Dividend (ttm) | $0.16 |
| Dividend Yield | 0.48% |
| Ex-Dividend Date | Dec 23, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | 13.89% |
| Volume | 18,498 |
| Open | 34.30 |
| Previous Close | 34.21 |
| Day's Range | 33.77 - 34.30 |
| 52-Week Low | 23.46 |
| 52-Week High | 35.68 |
| Beta | n/a |
| Holdings | 107 |
| Inception Date | Jun 11, 2025 |
About TMED
Fund Home PageThe T. Rowe Price Health Care ETF (TMED) is an exchange-traded fund. The ETF currently has 25.69m in AUM and 99 holdings. TMED is an actively managed ETF, aiming to outperform its respective sector index TMED was launched on Jun 11, 2025 and is issued by T. Rowe Price.
Top 10 Holdings
49.95% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 16.39% |
| UnitedHealth Group Incorporated | UNH | 5.99% |
| Gilead Sciences, Inc. | GILD | 4.41% |
| Thermo Fisher Scientific Inc. | TMO | 4.34% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 4.02% |
| Danaher Corporation | DHR | 3.51% |
| Cencora, Inc. | COR | 3.29% |
| Insulet Corporation | PODD | 2.74% |
| Agilent Technologies, Inc. | A | 2.65% |
| Stryker Corporation | SYK | 2.62% |
Performance
TMED had a total return of 38.63% in the past year, including dividends. Since the fund's inception, the average annual return has been 31.34%.
News
Active Healthcare Stocks ETF TMED Spiked in 1H
Healthcare stocks have boosted the ETF space in recent weeks. Despite some potential headwinds, the sector and its related thematic ETFs, like active healthcare ETF TMED, have performed.
T. ROWE PRICE ADDS THREE NEW TRANSPARENT SECTOR OFFERINGS TO ITS ACTIVE ETF ROSTER
BALTIMORE, June 12, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the addition of three new active transparent equity exchange-traded funds...